13. 多発性硬化症/視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


臨床試験数 : 3,342 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 266 - 標的パスウェイ数 : 240

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04764383
(ClinicalTrials.gov)
January 1, 202218/2/2021Histaminergic Basis of Fatigue in Multiple SclerosisHistaminergic Basis of Fatigue in Multiple SclerosisMultiple SclerosisDrug: L-Histidine;Drug: Placebo;Drug: LodosynUniversity of MiamiNULLWithdrawn18 Years60 YearsAll0Phase 2United States
2NCT03266965
(ClinicalTrials.gov)
March 23, 20184/7/2017Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel ApproachHistaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel ApproachMultiple SclerosisDrug: Carbidopa;Dietary Supplement: L-HistidineUniversity of MiamiUnited States Department of DefenseCompleted18 Years60 YearsAll18Phase 1United States
3NCT00630383
(ClinicalTrials.gov)
February 200827/2/2008Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.Multiple SclerosisBiological: Live Hookworm Larvae;Other: HistamineUniversity of NottinghamNULLWithdrawn18 Years60 YearsBoth0Phase 2United Kingdom